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Background: Wound healing is an intricate process whereby the skin repairs itself after injury. The
epithelial-mesenchymal transition (EMT) is associated with wound healing and tissue regeneration. Naphthochalcone
derivatives have various pharmaceutical properties. We investigated the effect of a novel naphthochalcone derivative,
2-(5-(2,4,6-trimethoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl)naphthalen-1-ol (TDPN), on dermal wound healing in vivo and
the migration of keratinocytes in vitro.
Result: We investigated the effect of TDPN on signaling pathway and epithelial-mesenchymal transition through protein
and transcriptional expression. The TDPN treatment accelerated dermal closure about 3 days and remodeling of dermis.
We found that treatment with TDPN induced the migration of keratinocytes but not cytotoxicity. TDPN induced the
phosphorylation of ERK and AKT. TDPN-treated cells showed loss of adherence protein and showed induction of the
transcriptional factor Slug, mesenchymal marker, and fibronectin. Moreover, TDPN treatment induced the expression of
matrix metalloproteinase-1 (MMP-1), which degrades specific components of the extracellular matrix, thereby providing
new substrates that facilitate migration and invasion. MMP expression is considered to be one of the major attributes
acquired by cells after EMT.
Conclusion: We propose that a novel naphthochalcone derivative TDPN is capable of promoting keratinocyte
migration via the induction of EMT resulting acceleration of wound closure and matrix remodeling.
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Skin is the outermost organ of body that provides a barrier
function to the body. In the epidermis layer of the skin, ker-
atinocytes are the major cell population, constituting more
than 90 % of all the cells [1]. When injuries to the skin
occur, the keratinocytes at the wound site undergo mor-
phologic alterations, changing from sedentary cells to mi-
gratory cells [2]. The phenotype of the migratory cells* Correspondence: moonjcho@jejunu.ac.kr
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adhesion during the re-epithelialization stage. This pheno-
type partially resembles the epithelial to mesenchymal tran-
sition (EMT) process, which plays a critical role in cancer
metastasis [2]. During both re-epithelialization and cancer
metastasis, cells that undergo EMT lose contact with each
other and the extracellular matrix (ECM) [3]. The ECM
may be degraded by matrix metalloproteinases (MMPs),
which represent a family of zinc-containing endopeptidases.
The relationship between the EMT and MMPs has been
clarified. MMP expression is considered to be one of the
major attributes acquired by epithelial cells after they
undergo the EMT [4]. MMPs, such as MMP-1, MMP-2,
MMP-9, and MMP-13, are frequently associated withle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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tion. Membrane type 1-MMP (MT1-MMP) is spatially and
temporally regulated during MCF10A cell migration owing
to its mediation of pericellular proteolysis of the laminin-5
(Ln-5) g2 chain [5]. The EMT is influenced by a wide range
of regulatory factors. The signaling pathways for PI3K/
AKT/mTOR and MAPK (ERK) are reported to be involved
in the regulation of EMT [2, 6]. Increased phosphorylation
of AKT has been implicated in the induction of the EMT
and cell migration [7]. Furthermore, the transcriptional fac-
tors Snail and Slug play essential roles in cell migration.
Slug expression has been shown to be up-regulated in the
wound margins in the in vitro, ex vivo, and in vivo settings
[8]. In Slug-null mice, re-epithelialization is reduced, com-
pared with wild-type mice [8].
Pure chalcones, which are extracted from plants, display
interesting biological properties, such as antioxidant, cyto-
toxic, anticancer, and antimicrobial activities [9]. Naphtho-
chalcone is a precursor to a variety of pharmaceutical
agents. Naphthochalcone derivatives, which can be isolated
from nature or biochemically synthesized, show various
pharmaceutical effects [10]. One of the newly synthesized
naphthochalcone derivatives, 1-(naphtho[2,1-b]furan-2-
yl-carbonyl)-3,5-disubstituted-2,3-dihydro-1H-pyrazole,
has been characterized by elemental analysis and in
spectral studies. This compound has been evaluated for
antimicrobial activity [11]. The compound (hydroxyphenyl)
naphthol sulfonamide could be useful in optimizing 17β-
HSD1 inhibitors for the treatment of endometriosis [12].
Another derivative, of methyl-1-hydroxy-2-naphthoate,
may inhibit lipopolysaccharide-induced inflammatory re-
sponses in macrophages via suppression of the NF-κB,
JNK, and p38 MAPK pathways [13]. Regarding structural
analogues of the flavones, alpha-naphtoflavone promotes
pro-collagen production in skin fibroblasts and is suggested
to have anti-aging effects [14]. Recently we have screened
series of compounds for promoting migration and prolifer-
ation of HaCaT cells and found that novel naphthochalcone
derivative, 2-(5-(2,4,6-trimethoxyphenyl)-4,5-dihydro-1H-
pyrazol-3-yl)naphthalen-1-ol (TDPN) (Fig. 1) had good
activity.
The present study was aimed to examining whether
novel naphthochalcone derivative (TDPN) exerts any ef-
fects on process of wound healing and, if so, what areFig. 1 Structure of -(5-(2,4,6-trimethoxyphenyl)-4,5-dihydro-1H-pyrazol-
3-yl)naphthalen-1-ol (TDPN)the underlying mechanisms responsible for the action of
TDPN. A murine excisional wound healing model
in vivo and experiments using human keratinocyte cell
line in vitro indicated TDPN accelerated wound closure
by activating keratinocyte movement via inducing EMT
like change. The results of this study provide novel drug
candidate of cutaneous skin wound.
Methods
Reagent
The novel naphthochalcone derivative, 2-(5-(2,4,6-tri-
methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl)naphthalen-
1-ol (TDPN) (Fig. 1), was synthesized and kindly provided
by Professor Youngho Lim (Division of Bioscience and
Biotechnology, Konkuk University, Seoul, Korea). TDPN
stock solutions were stored as aliquots at −20 °C, and were
diluted to the final concentration before use.
Cell culture
The human keratinocyte cell line HaCaT was cultured in
RPMI medium that was supplemented with 10 % fetal
bovine serum (FBS; GIBCO) and 1 % penicillin/strepto-
mycin (PAA). Cells were incubated in a humidified at-
mosphere at 37 °C in 5 % CO2.
Scratch wound healing assay
Because the doubling time of HaCaT cells is approxi-
mately 24 h, cells were seeded at 50 % confluency in cul-
ture dishes 24 h before the wound healing scratch assay.
Therefore, the experiment was performed when cells
reached monolayer formation. A scratch was made in
the cell monolayer by drawing a sterile p-200 pipette tip
across the surface of the culture dish. After the scratch
was made, the culture medium was supplemented with
TDPN. Dimethyl sulfoxide (DMSO; Amresco) treatment
was used as the control. At 0 h and 24 h post-treatment,
photographs of the cell monolayer were acquired at 4X
magnification using the Olympus IX70 microscope
equipped with a digital camera. The scratch was mea-
sured using the ImageJ software, and the difference be-
tween the initial and final width of the scratch was
calculated.
MTT assay
Cells were seeded on 96-well plates at 200 μl of cells
which have density of 3 × 104 cells/ml for each wells.
Cells were treated with TDPN or DMSO for 24 h. MTT
solution (10 μl of 5 mg/ml solution; Amresco) was added
to each well and incubated for 37 °C for 4 h. Subsequently,
the medium was gently removed and replaced with 150 μl
of DMSO and incubated for 30 min with shaking to dis-
solve the precipitate. The samples were measured at an
absorbance of 570 nm in a spectrophotometer [15].
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Cells were treated with TDPN or DMSO in time-
dependent and dose-dependent manners. The cells were
harvested by scraping and underwent lysis in RIPA buf-
fer. The BCA method (Thermo Scientific) was used for
protein concentration determination. The extracts were
analyzed by SDS-PAGE followed by Western blotting
with appropriate antibodies.
The following antibodies were used for Western blotting:
p21 (catalogue no. 2947), AKT (9272), phosphorylated
AKT (9271S), ERK (4695), Slug (9585S), and GAPDH
(2118) were from Cell Signaling Technology; E-cadherin
(610181) and Zo-1 (610966) were from BD Science Trans-
duction; cyclin E (sc-247), cyclin D1 (sc-246), p53 (sc-126),
phosphorylated ERK (sc-7383), collagen I (sc-25974), colla-
gen III (sc-28888), and fibronectin (sc-9068) were from
Santa Cruz Biotechnology; and MMP-1 (444209) was from
Calbiochem. The secondary antibodies used in the Western
blotting were anti-mouse (PI-2000; Vector Laboratories)
anti-rabbit (PI-1000; Vector Laboratories), and anti-goat
(AP-107P; Millipore). The blots were analyzed using the
ImageJ software. The relative change in the ratio of the tar-
get protein to the DMSO control was determined.
RT-PCR
Cells were seeded in a 60-mm culture dish and treated with
TDPN. RNA from the treated cells was extracted using the
Trizol reagent (Invitrogen). Then, 2 μg of total RNA were
used to synthesize cDNA synthesis using a Reverse Tran-
scriptase Kit (Promega). The resulting cDNA was used for
RT-PCR using the G-Taq kit (Cosmo Genetech, Seoul,
Korea) according to the manufacturer’s instructions.
RT-PCR was performed using the following gene-
specific primers (forward and reverse primers, respect-
ively), selected using the Blast Primer program: for GAP
DH, 5′-GAAGGTGAAGGTCGGAGTC-3′ and 5′-GA
AGATGGTGATGGATTTC-3′; for p53, 5′-ACACGCTT
CCCTGGATTGG-3 and 5′-CTGGCATTCTGGGAGC
TTCA-3′; for p21, 5′-GTCAGTTCCTTGAGCCG-3 and
5′-GAAGGTAGAGCTTGGGCAGG-3′; for MMP-1, 5′-
AGGGGAGATCATCGGGAC-3′ and 5′-GGCTGGACA
GGATTTTGG-3′; for MMP-2, 5′- AACACCTTCTATG
GTGCCC-3′ and 5′-ACGAGCAAAGGCATCACCA-3′;
and for MMP-7, 5′-TACAGTGGGAACAGGCTAGG-3′
and 5′-GGCACTCCACATCTGGGC-3′. The results were
analyzed using the ImageJ software. The relative change in
the ratio of the target protein to the DMSO control was
determined.
MMP zymography
MMP zymography was performed according to the method
described by Gogly et al. [16], with the following modifica-
tion: 8 % sodium dodecyl sulfate (SDS) gels that contained
gelatin (0.01 mg/ml) were used. The SDS in the gels wasremoved by incubating the gels twice (30 min each) in
200 ml of 2.5 % Triton X-100 at 4 °C. Thereafter, the gel
slabs were incubated at 37 °C overnight in the incubation
buffer. The gels were then fixed and stained for 1 h with
0.05 % Coomassie Blue R-250. The molecular mass protein
markers were readily visible as stained bands against the
lighter blue color of the stained gelatin background. Gelati-
nase activity was apparent as clear zones of lysis (negative
staining) against the blue background. The gels were
scanned to create a permanent record of the results.Transwell invasion assay
The Transwell invasion assay was performed using a com-
mercial Transwell plate (Corning). Cells were harvested by
trypsinization and 7x104 cells/well in 100ul of medium
were seeded into the wells of the insert. The receiving wells
were set up with medium containing FBS as a chemo-
attractant. After 24 h, media in insert wells was replaced by
100ul of free serum medium containing TDPN, TGF-β1,
or DMSO. Invasive cells in the receiving wells were col-
lected by trypsinization and counted by hemacytometer.Hoechst stain proliferation assay
The Hoeschst stain proliferation assay was performed as
previously described [17]. 200 μl of cells at a density of
3 × 104 cells/ml were seeded into the wells of 96-well
plates. Cells were treated with TDPN or DMSO for 24 h.
Hoechst 33342 solution (1 μl of 10 mM stock solution;
Sigma) was added to each well and incubated for 37 °C for
30 min. Cell proliferation was estimated by direct meas-
urement of changes in cell fluorescence using a spectroflu-
orometer (SPECTRAFLUOR, Tecan). The instrument was
equipped with a 365-nm broadband filter for the excita-
tion beam and a 450-nm narrowband interference filter
plus a UV blocking filter for the emitted lightECIS migration assay
HaCaT cells were seeded at a density of 1 × 105 cells/cm2
into ECIS arrays and impedance was measured using an
ECIS instrument. Wounding pulses of 2400 mA were
applied for 20 s at 6400 kHz. Media was then replaced
by media containing TDPN or TGFβ1 or DMSO. The
results were exported to the ECIS program.Trypan blue cell counting assay
5x104 cells/well were seeded on 24-well plates. After
24 h of incubation, cells were treated with TDPN or
DMSO in various concentrations for 24 h. All cells in
each well were collected by trypsinization. The live cells
were identified and counted by trypan blue staining.
This experiment was repeated three times.
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6-week old male ICR mice (n = 5 for each group: control
and treatment TPDN) were chosen for the experiment.
The fur was removed with an electronic hair clipper and
removal cream. Dermal wound was placed on the middle
of a back using an 8 mm punch instrument. In dermal
wound site, we punch out whole dermis including subcuta-
neous fat layer (deep punch) and appendages of skin didn’t
preserved. A few days later, granulation tissue and scab
were formed at wound and we could confirm the epider-
mis and dermis were filled from surroundings of wound in-
stead of granulation tissue. 200 μl of TDPN was applied to
the wounds of the experimental group in concentrations of
200 μM (dissolved with Vaseline) for 20 days, while the
control group was treated with same amount of DMSO
(dissolved with Vaseline). Usually in vivo experiment, com-
pounds have treated to animal approximately 100 ~ 200
times higher concentration of in vitro. Because process of
the delivery and conversion of ingredients may cause lower
of active material to reach to target points. However, in this
study, the compound was applied to wound site directly,
therefore we only applied just 10 times concentration of
TDPN compared to in vitro. The wound was pictured
every three day and the rate of wound closure was calcu-
lated as relative % of original wound area using Image J
program. Skin samples were collected from mice at each of
the wounding time points (9, 12, 15 days post-wounded)
and fixed in 4 % formaldehyde. We cut formalin-fixed,
paraffin-embedded tissues into 3um sections, stains all sec-
tions simultaneously by using routine hematoxylin–eosin
(H-E) and Masson’s trichrome stain methods. The slides
were reviewed by an Olympus BX51 microscope (Olympus
Corp., Tokyo, Japan) with the apochromatic objective lens
and a 0.85 numeric aperture.
Results
TDPN induces the migration but not the proliferation of
keratinocytes
Re-epithelialization involves the migration and proliferation
of keratinocytes. In the present study, we investigated these
two processes using the MTT assay and scratch wound
healing assay for keratinocytes (HaCaT cells) treated with
different concentrations of 2-(5-(2,4,6-trimethoxyphenyl)-
4,5-dihydro-1H-pyrazol-3-yl)naphthalen-1-ol (TDPN) for
24 h. In the migration assay, TDNP promoted HaCaT cell
migration dose-dependently up to 20 μM. However, there
was little difference between 10 and 20 μM (Fig. 2a). It has
been reported that TGF-β can induce EMT and migration
of various cell types, including keratinocytes ([20, 31],
Rasanen et al., 2010). To compare their abilities to induce
migration, we performed migration assay comparing the
ability of TGF and TDPN to induce migration, by both the
ECIS system (Fig. 2b) and the Transwell invasion assay
(Fig. 2c). These results demonstrated that TDPN inducedmigration and invasion comparably to TGF-β in the same
time period of treatment.
Since migration rate may be influenced by proliferation
rate, we tested cell growth. And keratinocyte proliferation
was not affected by TDPN proven by three independent
assays such as MTT assay, hemacytometer counting assay
and in the proliferation Hoechst staining assay (Fig. 2d).
These results also showed no significant changes between
treated and untreated cells. To confirm the results, pro-
teins related to the cell cycle were investigated in the
treated cells. The levels of cyclin-dependent kinases E and
D1, p53, and p21 were not significantly changed by TDPN
(Fig. 2e). These data suggest that TDPN induces the mi-
gration but not the proliferation of keratinocytes.
ERK and AKT phosphorylation is involved in promotion of
keratinocyte migration by TDPN
It is well-known that mitogen-activated protein (MAP)
kinase family members, ERKs, as well as the PI3K/AKT
pathway, are important for the regulation of cell migra-
tion. Therefore, we investigated the expression levels of
regulatory proteins related to cell migration, such as
AKT and ERK. Keratinocytes were treated with TDPN
for different time periods and protein lysates were
assayed for phosphorylation of AKT and ERK. We used
a stock of TDPN containing approximately 0.05 %
DMSO. Each time point, cells treated either DMSO or
TDPN in DMSO were collected and assayed by western
blot analysis. The relative intensity between TDPN and
control group at each specific time point was calculated
(Fig. 3a). Within 2 h ERK and AKT signals were acti-
vated. These signals were increased dose-dependently at
2 h time point (Fig. 3b) and the treatment of specific in-
hibitors against ERK and AKT attenuate TDPN induced
phosphorylation (Fig. 3c). To identify the TDPN induced
migration of keratinocyte was mediated by ERK and
AKT signaling, we performed a wound healing assay in
which cells were pretreated with a PI3K inhibitor
(LY49002, 50 μM) and a MEK inhibitor (PD98059, 50 μM)
then treated with TDPN or left untreated. The results dem-
onstrated that inhibiting the AKT and ERK pathways abol-
ished the effects of TDPN on migration (Fig. 3d).
TDPN induces EMT-like change
It has been reported that EMT occurs in keratinocytes
at wound sites during the re-epithelialization stage [18,
19]. Thus, we investigated whether TDPN promotes re-
epithelialization through EMT. We treated TGF-β1
(10 ng/ml) and TDPN for 24 h and observed morpho-
logical and biochemical changes. On above condition,
morphological changes were not dramatic (Additional
file 1: Figure S1). It has been reported that TGF-β in-
duces invasion and changes the cell size of several cell
types including epithelial cells and keratinocytes [20-22].
Fig. 2 TDPN effects on migration and proliferation of HaCaT cell line. Migration of HaCaT cells were measured by scratch wound assay and ECIS system.
Scratch wound healing assay of HaCaT cells treated with different concentrations of TDPN for 24 h. Cells were seeded with density 3 × 104 cells/ml 24 h
before scratch and treated. Distance of the scratch was measured after 24 h treated with TDPN (a). Cells were subjected to ECIS migration assay in the
absence or the presence of TDPN or TGF-β as indicated. Cells were allowed to grow to confluence and initial resistance was measured for few hours. Cells
were subjected to high voltage to initiate wound at 3 h resulting in the drop of resistance. Remaining cells were allowed to migrate in the presence or
absence of TDPN and resistance changes were measured for 24 h after the creation of wound (b). Represented pictures are shown from 3 independent
experiments. Invasion of TDPN treated cells were measured using transwell chambers as described in methods (c). Proliferation of keratinocyte cells were
measures three different methods; MTT assay, Hoechst staining, and trypan blue counting assays (d). Cells were seeded for 24 h, then treated with various
concentrations of TDPN or DMSO for 24 h. After treatment, cells were collected and counted in Trypan blue assay or incubated with Hoechst 33342 or
MTT reagent. Results were measured by flourescence spectrometer or spectrometer. Western blot of cell cycle-related proteins comparing cells treated with
10 μM TDPN and untreated cells. Protein lysate from cells treated with TDPN for 24 h were taken using RIPA buffer. The expression level was measured by
comparing the density of the target protein to GAPDH (e). (*)P < 0.05 compare to control group
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Fig. 3 ERK and AKT phosphorylation is involved in promotion of keratinocyte migration by TDPN. HaCaT cells were treated with either DMSO or
10 μM TDPN for the indicated time (a) or the indicated dose for 2 h (b) and harvested for western blot analysis. Band intensity is presented as
mean ± SE of relative to GAPDH and ratio between pAKT or pERK of TDPN and pAKT or pERK of control DMSO treatment from least 3
replications. (*)P < 0.05 compare to control group) (c) Cells were pre-treated with PI3K inhibitor (LY49002, 50 μM,) or MEK inhibitor (pd98059,
50 μM,) for 24 h, then treated with TDPN for 1 h and harvested for western blot analysis, to assess the involvement of the ERK and AKT signaling
pathways. (d) After co-treatment of TDPN and PI3K inhibitor (LY49002, 50 μM) or MEK inhibitor (pd98059, 50 μM) for 24 h, scratch wound healing
assay were performed. Distance of the scratch was measured relative to control after 24 h of treatment with TDPN. (*)P < 0.05)
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Fig. 4 TDPN induces EMT like change. HaCaT cells were treated with TDPN (10 μM) for the indicated time (a) or at the indicated dose (b) and
harvested for western blot analysis. (data presented as mean of relative to GAPDH ± SE from least 3 replications, (*)P < 0.05 compare to control
group). (c) HaCaT cells treated with 10 μM TDPN for 24 h. After treatment, the conditioned media from the cells was concentrated using amicon
centrifugation. Protein in media was collected and analysed by western blot for Collagen I, Collagen III, Fibronectin, and MMP1. (d)Transcriptional
expression of MMPs in HaCaT cells treated with TDPN (10 μM for 24 h). After treatment, total RNA from each cells was taken by Trizol reagent
and analysed by RT-PCR for MMP1, MMP2, MMP7. GAPDH was used as a control. (data presented as mean of relative to GAPDH ± SE from least 3
replications, (*)P < 0.05 compare to control group)
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TGF-β on in vitro varies depending on cell types. HaCaT
cells treated with TGF-β1 for 24 h only form actin stress
fibers but morphology does not change [23]. However,
in cellular level, main EMT markers such as epithelial
marker proteins Zo-1 and E-cadherin, and mesenchymal
marker, transcriptional factor Slug changed (Fig. 4a).
Western blot results revealed that TDPN treatment in-
creased Slug expression and decreased the E-cadherin
and Zo-1 in a time-dependent manner (Fig. 4a) and
dose-dependent manner (Fig. 4b). This suggests that
TDPN treatment causes the loss of cell-cell adhesion. In
addition, the level of the mesenchymal marker fibronec-
tin was slightly increased (Fig. 4d).
In both EMT tumors and migrating keratinocytes,
degradation and remodeling of the ECM are needed.
The EMT pathway has been reported to involve MMP
expression [4]. In the present study, zymography revealed
that the levels of MMP-2 and MMP-9 were not changed
by TDPN treatment (Additional file 2: Figure S2). How-
ever, the Western blot results for TDPN-treated cells




Fig. 5 Wound closure after a full-thickness dermal excision. Male ICR mice
They were either muck treated or treated with cutaneous application of TD
(a). The averages of opened wound area were measured by image program
expressed as means ± SE from 6 wounds in each group till day 9, 4 woundincreased (Fig. 4c). The transcriptional expression pattern
showed a similar result (Fig. 4d).
TDPN accelerated dermal wound healing
Full-thickness excisional wound were made on the dorsal
of mice and TDPN or Vaseline were applied to wound site
topically every day. Hereby, we investigated the effects of
TDPN on skin remodeling phase. It could affect scar for-
mation and faster resolving collagen deposit. TDPN
treated mice exhibited a faster wound closure then muck
treated animals as early as day 9 (Fig. 5a). The average of
opened wound area were measured by image program
and the rate of closure of TDPN treated was 3 day faster
than untreated ones (Fig. 5b). Tissue samples were taken
at day 9, 12 and 15 post-wounded and performed H&E
staining. On day 9, TDPN treated wound revealed that
epidermal closure is complete but dermal closure is not
sufficient to have open area (yellow arrow) and inflamma-
tion and necrosis is still remain in outer skin (Fig. 6a).
Whereas muck treated wound showed that necrosis and
inflammation accompanied in wound site and epidermal
leading edge is observed (black arrow) but epidermal(6 weeks of age) underwent a full-thickness 8 mm excisional wounding.
PN (200 μM) daily. The wound closure was pictured every three day
and plotted as relative % of original wound (b). The values were
s at day12 and 2 wounds at day 15
Fig. 6 Histological findings of dermal wound tissues during the healing process. Dermal specimens were obtained from ICR mice either TDPN
treated (a, c and e) or muck treated (b, d, and f) as in Fig. 5, at day 9 (a and b), day 12 (c and d) or day 15 (e and f). They were subjected to
H-E staining (a-f) or Masson Trichrome staining (g-j). Yellow arrow indicated open area. Black arrow indicated epidermal leading edge. Represented
pictures are shown from 2 wounds in each group at each day
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in dermis is incomplete and dermal closure is ongoing
(Fig. 6b). On day 12, in TDPN treated wound, epidermal
and dermal closure is complete and hair follicle start to
show but not yet start differentiation. Contraction of
granulation tissue squeezes hair follicle to wound direction
(Fig. 6c). In muck treated wound, granulation tissue for-
mation is processed and dermal closure is complete,however, the proliferation of epidermis is not sufficient
and the epidermal closure is incomplete (Fig. 6d). On day
15, in TDPN wound, epidermal and dermal closure is
complete perfectly and glands differentiation is processing
throughout the wound site (Fig. 6e). Day 15 muck treated
wound still have no sign of a nodule that resembled early
sweat or sebaceous glands (Fig. 6f). Collagen deposits were
stained by Masson Trichrome (Fig. 6g-j). In TDPN treated
Seo et al. Journal of Biomedical Science  (2015) 22:47 Page 10 of 12animal, until day 12 collagen deposition is still ongoing
and distribution of collagen fiber is uneven (Fig. 6g) how-
ever on day 15, collagen density is high and evenly distrib-
uted as normal dermis (Fig. 6h). In muck treated wound,
the collagen deposit did not show much difference com-
pared to TDPN treated (Fig. 6i-j). Results suggested accel-
erated wound closure may attributed by faster epidermis
differentiation.
TDPN promote epidermis development via keratinocyte
activation
We performed Ki-67 antibody staining for detect prolif-
eration (Fig. 7). In both case, the day 9 show highest
proliferation index (Fig. 7a-f ). In the TDPN group at day
12 and muck treated group at day 15, cells located at the
bilayer of epidermis (yellow arrow) show strong reaction
as seen in normal epidermis (Fig. 7b,f ). However, on day
15, TDPN treated group show high proliferation not
only epidermal bilayer but also around nodules that re-
sembled early sweat or sebaceous glands (Fig. 7c). These
results suggested that TDPN mainly activated epidermal
keratinocyte rather than dermal fibroblast.
Discussion
Our results reveal that the novel naphthochalcone de-
rivative TDPN show faster wound closure and matrix re-
modeling (Figs. 5 and 6) via promoting the migration
but not the proliferation of keratinocytes (Fig. 2).Fig. 7 Proliferation of dermal wound tissues during the healing process. D
(a, c and e) or muck treated (b, d, and f) as in Fig. 5, at day 9 (a and b), da
was measured by ki-67 antibody staining. Represented pictures are shownImportantly, we observed promotion of the EMT path-
way in the TDPN-treated cells. The expression levels of
the adherence junction protein E-cadherin and tight
junction protein ZO-1 were reduced in the cells treated
with TDPN. Also, the expression levels of the transcrip-
tional factor Slug, as well as those of the mesenchymal
marker fibronectin were induced in these cells (Fig. 4).
Furthermore, the ERK and AKT signaling pathways were
found to be involved in TDPN induction of EMT, as evi-
denced by the induction of phosphorylation of ERK and
AKT which was confirmed by pretreatment AKT inhibitor
(LY49002, 50 μM) or ERK inhibitor (PD98059, 50 μM) at-
tenuated effect of TDPN (Fig. 3). As a consequence of the
EMT, MMP-1 (but not MMP-2 or MMP-9) was found to
be significantly induced. Following the induction of
MMP-1 in the TDPN-treated cells, the ECM proteins col-
lagen I and collagen III were significantly degraded.
The TDPN mainly stimulate keratinocyte not fibro-
blast. Keratinocyte migration, a part of cell proliferation
stage, plays an important role during the wound healing
[24]. Several approaches have been used to study new
compounds and new pathways that promote migration
and wound healing [25, 26]. For example, Protection ef-
fects of green tea extract (EGCG) against UV were
found to be involved in the proliferation of normal hu-
man keratinocytes [27]. EGCG-induced Erk phosphoryl-
ation and activation of the Akt pathway was found to
promote keratinocyte survival [28]. However, in ourermal specimens were obtained from ICR mice either TDPN treated
y 12 (c and d) or day 15 (e and f). Proliferation of cell in wound site
from 2 wounds in each group at each day
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on the proliferation of keratinocytes. VPA cutaneous
wound healing by increasing the motility of HaCaT kera-
tinocytes through ERK and phosphatidylinositol 3-kinase
(PI3-kinase)/Akt signaling pathways [28].
The epithelial-mesenchymal transition (EMT) is one
of the major factors that affect cell migration associated
with wound healing and tissue regeneration [18, 19].
Loss of cell junctions is considered to be a crucial
marker for EMT [17]. Extensive previous studies have
focused on how tight junctions are down-regulated in
EMT [29, 30, 5]. In addition, during the early stage of
re-epithelialization, when cells undergo EMT, reduced
cell-cell contacts allow the cells to migrate. EMT down-
regulation of the cell junction protein E-cadherin
appears to involve regulation by Wnt or TGF-β via indu-
cible activation of kinase pathways that modulate GTPase,
Smads, PI3Ks, MAP kinases, β-catenin, and activate tran-
scription factors, including LEF-1, Snail, Slug, and Scatter,
ultimately leading to repression of the E-cadherin gene
[31]. Apart from the loss of cell junctions, the increased ex-
pression levels of Slug and mesenchymal marker act as a
marker for EMT [19, 32]. Slug, a key transcription factor is
responsible for the down-regulation of E-cadherin in both
explanted human skin and primary keratinocytes [33].
The cell migration is regulated by various signaling
pathways. The MAPK signaling pathways are associated
with cell migration [34], as well as the EMT pathway
[35, 36], and the PI3K/AKT signaling pathway has also
been implicated in cell migration [6, 37] and EMT [38].
TDPN induced phosphorylation of ERK and AKT in time-
and dose-dependent manners (Fig. 3). A previous report
showed that transforming acidic coiled-coil protein 3
(TACC3) induced EMT and migration through induction
of the AKT and ERK pathways [37]. Furthermore, it has
been reported that inhibition of the ERK and AKT path-
ways leads to inhibition of the induction of EMT by
TGF-β1 [39]. Our results revealed that the phosphoryl-
ation of signaling pathway proteins AKT and ERK were
induced early in TDPN treatment, while changes of
EMT markers such as Slug E-cadherin detected later.
We suggest that TDPN triggers early signals in the
EMT pathway (Figs. 3 and 4).
Matrix metalloproteinases (MMPs), which are extracellu-
lar proteases that are highly expressed at wound sites, de-
grade specific components of the ECM, thereby providing
new substrates that facilitate migration and invasion [40].
The relationships between EMT and MMPs have been de-
scribed. MMP expression is considered to be one of the
major attributes acquired by epithelial cells after EMT [4].
MMP-2 and MMP-9 have been reported to play essential
roles in the EMT in the avian embryo [41, 42]. Interestingly,
our enzymatic activity results do not accord with the results
in the previous report, in that the levels of MMP-2 andMMP-9 were not changed in our treated cells. However,
MMP-1 (type I collagenase) is needed in the epidermis for
re-epithelialization [40]. In human oral keratinocytes,
MMP-1 mRNA was expressed while the keratinocytes cov-
ered the wound surface [43]. In agreement with those re-
sults, MMP-1 was induced in the TDPN-treated cells in the
our study (Fig. 4). In vitro keratinocyte culture, collagen I
and collagen III were significantly degraded in the TDPN
treatment group. Given that MMP-1 is a collagenase, its in-
duction would lead to the degradation of the collagen help-
ing keratinocyte migration at the margin of dermis.
Conclusion
The finding of novel compound – TDPN – to promote
wound healing via keratinocyte migration supplies a
good tool for studying wound healing mechanism and
possible drug candidate.
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